BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36867850)

  • 1. Myelodysplastic Syndrome with Excess Blasts 2 (MDS-EB-2): A Historical Overview and Review of Forthcoming Classifications.
    Tan JS; Gardner JA; Devitt KA; Conant JL
    J Assoc Genet Technol; 2023; 49(1):24-30. PubMed ID: 36867850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of the 5
    Lee C; Kim HN; Kwon JA; Yoon SY; Jeon MJ; Yu ES; Kim DS; Choi CW; Yoon J
    Ann Lab Med; 2023 Sep; 43(5):503-507. PubMed ID: 37080752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization and prognosis of mutant TP53 acute myeloid leukemia and myelodysplastic syndrome with excess blasts.
    Shen K; Hu DY; Zhang ZB; Guo YS; Zhang FH; Chen SN
    Int J Lab Hematol; 2023 Jun; 45(3):344-352. PubMed ID: 36860196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What's in a Name? The Many Classifications of Acute Myeloid Leukemia with Dysplasia.
    Taylor NC; Conant JL; Gardner JA
    J Assoc Genet Technol; 2023; 49(2):93-99. PubMed ID: 37269294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Consensus Classification of myelodysplastic syndromes and related entities.
    Hasserjian RP; Orazi A; Orfao A; Rozman M; Wang SA
    Virchows Arch; 2023 Jan; 482(1):39-51. PubMed ID: 36287260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia.
    Chen X; Othus M; Wood BL; Walter RB; Becker PS; Percival ME; Abkowitz JL; Appelbaum FR; Estey EH
    Leuk Lymphoma; 2021 May; 62(5):1226-1233. PubMed ID: 33345655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms.
    Khanna V; Lu R; Kumar J; Molina A; Stehr H; Spiteri E; Spinner M; Silva O; Fernandez-Pol S; Tan B; Greenberg PL
    Leuk Res; 2024 Jan; 136():107433. PubMed ID: 38154193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new WHO and ICC classification systems for myelodysplastic syndromes and their impact on the clinical laboratory.
    Bruehl FK; Osman MM; Chen D; Dalland JC
    J Hematop; 2023 Jun; 16(2):65-71. PubMed ID: 38175439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.
    Grob T; Al Hinai ASA; Sanders MA; Kavelaars FG; Rijken M; Gradowska PL; Biemond BJ; Breems DA; Maertens J; van Marwijk Kooy M; Pabst T; de Weerdt O; Ossenkoppele GJ; van de Loosdrecht AA; Huls GA; Cornelissen JJ; Beverloo HB; Löwenberg B; Jongen-Lavrencic M; Valk PJM
    Blood; 2022 Apr; 139(15):2347-2354. PubMed ID: 35108372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of plasma cell neoplasia and myelodysplastic syndrome with excess blasts: case reports and literature review.
    Yan W; Qu XY; Li H; Li YC; Li Y; Yao K; Yang W; Wang HH
    Ann Palliat Med; 2021 Dec; 10(12):12431-12440. PubMed ID: 35016480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new diagnostic criteria for myelodysplasia-related acute myeloid leukemia is useful for predicting clinical outcome: comparison of the 4th and 5th World Health Organization classifications.
    Park HS; Kim HK; Kim HS; Yang Y; Han HS; Lee KH; Son BR; Kwon J
    Ann Hematol; 2022 Dec; 101(12):2645-2654. PubMed ID: 36220882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.
    Lee WH; Lin CC; Tsai CH; Tien FM; Lo MY; Ni SC; Yao M; Tseng MH; Kuo YY; Liu MC; Tang JL; Sun HI; Chuang YK; Chou WC; Hou HA; Tien HF
    Am J Hematol; 2023 Mar; 98(3):398-407. PubMed ID: 36588411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
    Niparuck P; Police P; Noikongdee P; Siriputtanapong K; Limsuwanachot N; Rerkamnuaychoke B; Chuncharunee S; Siriboonpiputtana T
    Diagn Pathol; 2021 Oct; 16(1):100. PubMed ID: 34717674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic characteristics of 665 patients with myelodysplastic syndrome in China: A single-center report.
    Wang X; Liu W; Wang M; Fan T; Li Y; Guo X; Yang X; Wang H; Xiao H; Zhang S; Quan R; Liu C; Tang X; Lv Y; Chen Z; Li L; Xu Y; Ma R; Hu X
    Oncol Lett; 2021 Feb; 21(2):126. PubMed ID: 33552247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms.
    Zhang Y; Wu J; Qin T; Xu Z; Qu S; Pan L; Li B; Wang H; Zhang P; Yan X; Gong J; Gao Q; Gale RP; Xiao Z
    Leukemia; 2022 Dec; 36(12):2875-2882. PubMed ID: 36224330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and comparison of 5th edition World Health Organization classification (WHO 2022) and International Consensus Classification proposals for MDS-SFB31.
    Liu L; Li B; Xu Z; Qin T; Jia Y; Qu S; Zhang Y; Wu J; Cai W; Pan L; Gao Q; Jiao M; Xiao Z
    Br J Haematol; 2024 Apr; ():. PubMed ID: 38654443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the International Consensus Classification and World Health Organization 5th edition classification to a series of myeloid neoplasms.
    Chopra S; Bailey NG
    Am J Clin Pathol; 2023 Dec; 160(6):566-570. PubMed ID: 37587830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.
    Falini B; Martelli MP
    Am J Hematol; 2023 Mar; 98(3):481-492. PubMed ID: 36606297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
    Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
    Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.